Fugitive Used Alias to Work in Biotech for Two Decades
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Ronald Fischer, a former doctor convicted of sexual assault and one of Rhode Island's most-wanted fugitives, spent roughly two decades on the run while working in the biotech industry under the alias Richard Graydon.
- Fischer's CV included stellar academic credentials, board certification, and claimed experience leading teams that successfully developed cancer drugs, though STAT's review found much of it appears to have been fabricated.
- At least one biotech company hired Fischer on a full-time basis, and at least two large pharmaceutical companies engaged him on a contractual basis, despite his two-decade fugitive status.
- An industry recruiter who spoke with Graydon told STAT his credentials "checked the right boxes" for top biotech and pharma roles, making it unsurprising he evaded scrutiny.
- The case raises questions about how companies vetting senior hires for drug-development work failed to detect a convicted fugitive whose resume was, in large part, apparently invented.
Why it matters: Biotech and pharma companies entrust senior hires with patient-facing drug development, yet a convicted sex offender with an apparently fabricated resume worked at multiple firms undetected for 20 years. The episode exposes a gap between the industry's reliance on pedigree-based hiring and the rigor of its background checks, and could pressure companies to tighten vetting for senior scientific staff.
